• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2006 Fiscal Year Final Research Report Summary

Identification of Cancer Stem Cells and Its Clinical Application for Treating Aggressive Neuroblastomas

Research Project

Project/Area Number 17390473
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatric surgery
Research InstitutionChiba Cancer Center Research Institute

Principal Investigator

NAKAGAWARA Akira  Chiba Cancer Center Res. Inst., Director, 研究局, 研究部長 (50117181)

Co-Investigator(Kenkyū-buntansha) TAKENOBU Hisanori  Chiba Cancer Center Res. Inst., Division of Pathology, Researcher, 病理研究部, 研究員 (60392247)
OZAKI Toshinori  Chiba Cancer Center Res. Inst., Division of Biochemistry, Senior Researcher, 生化学研究部, 上席研究員 (40260252)
OHIRA Miki  Chiba Cancer Center Res. Inst., Division of Biochemistry, Research scientist, 生化学研究部, 研究員 (20311384)
Project Period (FY) 2005 – 2006
KeywordsNeuroblastoma / Cancer stem cells / Stem cell markers / nestin / CD 133 / XCE / p73 / p63
Research Abstract

1. Identification of neuroblastoma stem-like cells marker genes
Three cell lines with characteristic phenotype, N-, I-and S-type cells, were subcloned from the neuroblastoma cell lines at Sloan-kettering Cancer Hospital. By using our in-house cDNA microarray carrying 5300 cDNAs, we have identified more than several genes specifically expressed in I-type cells which are believed to be very close to the neuroblastoma stem cell.
2. Expression of cancer stem cells markers in neuroblastomas in primary culture
To search for the neuroblastoma stem cells, we used 34 neuroblastomas in primary culture as well as 6 neuroblastoma cell lines. Most of the primary neuroblastoma cells formed spheres, in which some cells were positive for sustained BrdU labeling, suggesting the presence of cancer stem cells of neuroblastoma. We then tested the significance of the potential markers of neuroblastoma stem cells in primary culture cells. Both nestin and TUJ1 were preferentially positive in favorable tumor cells as compared to unfavorable cells. Especially, expression of nestin was significantly high in tumor cells obtained from patients under one year of age. Expression of p75NTR also showed the similar pattern, but its expression levels were relatively low. Interestingly, both p63 and p73, the variants of p53 tumor suppressor, were highly expressed in many. neuroblastoma cells in primary culture independently of the tumor stages. Therefore, they could be new stem cell markers which might initiate the genesis of neuroblastoma. The further study about the functional roles of their variants, the TA form and the delta-N form, should be needed.

  • Research Products

    (14 results)

All 2007 2006 2005

All Journal Article (13 results) Book (1 results)

  • [Journal Article] Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas.2007

    • Author(s)
      Abe M, Nakagawara A, et al.
    • Journal Title

      Cancer Lett. 247

      Pages: 253-258

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas.2007

    • Author(s)
      Abe M, Westermann F, Nakagawara A, Takato T, Schwab M, Ushijima T.
    • Journal Title

      Cancer Lett.

      Pages: 247:253-258

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan.2006

    • Author(s)
      Kaneko Y, Nakagawara A, et al.
    • Journal Title

      Pediatr. Blood Cancer 46

      Pages: 285-291

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Increased expression of pro-apoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with poor prognosis in human neuroblastomas.2006

    • Author(s)
      Machida T, Nakagawara A, et al.
    • Journal Title

      Oncogene 25

      Pages: 1931-1942

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma.2006

    • Author(s)
      Niizuma H, Nakagawara A, et al.
    • Journal Title

      Oncogene 25

      Pages: 5046-5055

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan.2006

    • Author(s)
      Kaneko Y, Kobayashi H, Watanabe N, Tomioka N, Nakagawara A.
    • Journal Title

      Pediatr. Blood Cancer

      Pages: 46:285-291

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Decreased expression of pro-apoptotic BMCCl, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with poor prognosis in human neuroblastomas.2006

    • Author(s)
      Machida T, Fujita T, Ooo M L, Ohira M, Isogai E, Mihara M, Hirato J, Tomotsune D, Hirata T, Fujimori M, Adachi W, Nakagawara A.
    • Journal Title

      Oncogene

      Pages: 25:1931-1942

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma.2006

    • Author(s)
      Niizuma H, Nakamura Y, Ozaki T, Ohira M, Isogai E, Kageyama H, Imaizumi M, Nakagawara A.
    • Journal Title

      Oncogene

      Pages: 25:5046-5055

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate-risk neuroblastomas.2005

    • Author(s)
      Ohira M, Nakagawara A, et al.
    • Journal Title

      Cancer Cell 7

      Pages: 337-350

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] LMO3 interacts with neuronal transcription factor, HEN2, and cts as an oncogene in neuroblastoma.2005

    • Author(s)
      Aoyama M, Nakagawara A, et al.
    • Journal Title

      Cancer Res. 65

      Pages: 4587-4597

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate-risk neuroblastomas.2005

    • Author(s)
      Ohira M, Oba S, Nakamura Y, Isogai E, Kaneko S, Nakagawa A, Hirata T, Kubo H, Goto T, Yamada S, Yoshida Y, Fuchioka M, Ishii S, Nakagawara A.
    • Journal Title

      Cancer Cell

      Pages: 7:337-350

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.2005

    • Author(s)
      Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y, Tokita H, Ohira M, Nakagawara A.
    • Journal Title

      Cancer Res.

      Pages: 65:4587-4597

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Neuroblastoma2005

    • Author(s)
      Nakagawara A.
    • Journal Title

      Chapter 5. Molecular and developmental biology of neuroblastoma.

      Pages: 41-53

    • Description
      「研究成果報告書概要(欧文)」より
  • [Book] Neuroblastoma2005

    • Author(s)
      Nakagawara A.
    • Total Pages
      41-53
    • Publisher
      Springer-Verlag
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2008-05-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi